Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

In the News

11:46 04 Oct 2022 OBLN

4 Penny Stocks Reddit Traders Are Buying Right Now

Looking for penny stocks to buy on Reddit? Check these 4 out for your watchlist The post 4 Penny Stocks Reddit Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

12:05 04 Oct 2022 OBLN

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger

SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their previously announced merger to be effective after the close of the market today, June 15, 2021. The shares of common stock of the combined company are expected to commence trading on The Nasdaq Capital Market on Wednesday, June 16, 2021, under the name ReShape Lifesciences Inc. and the trading symbol "RSLS.

12:00 04 Oct 2022 OBLN

Penny Stocks Are Heating Up, Here's 3 You Need to Know About

Are these the best penny stocks to watch right now? Take a look and decide for yourself The post Penny Stocks Are Heating Up, Here's 3 You Need to Know About appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

11:35 04 Oct 2022 OBLN

OBLN Stock Price: Over 20% Increase Explanation

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by over 20% during intraday trading. This is why it happened.

07:30 04 Oct 2022 OBLN

Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the "Special Meeting") on May 25, 2021, at 8:30 a.m. PT. All stockholders are highly encouraged to vote by phone or email on this critical transaction.

07:24 04 Oct 2022 OBLN

OBLN Stock Price: 30.04% Increase Explanation

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by 30.04% on Friday May 21. This is why it happened.

01:40 04 Oct 2022 OBLN

Top Penny Stocks to Buy Today? Here's 3 to Watch in 2021

Top penny stocks to buy today? Check these 3 out for your watchlist The post Top Penny Stocks to Buy Today?

07:30 04 Oct 2022 OBLN

Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders (the "Special Meeting") on May 25, 2021, at 8:30 a.m. PT. All stockholders are highly encouraged to vote by phone or email on this critical transaction.

04:32 04 Oct 2022 OBLN

Which Penny Stocks Are The Most Resilient During a Bear Market?

Is finding penny stocks to buy in May 2021? Take a look at these 3 industries for some inspiration The post Which Penny Stocks Are The Most Resilient During a Bear Market?

01:56 04 Oct 2022 OBLN

OBLN Stock: Over 7% Increase Intraday Explanation

The stock price of Obalon Therapeutics Inc (NASDAQ: OBLN) increased by over 7% during intraday trading. This is why it happened.

Financial details

Company Rating
Buy
Market Cap
30.57M
Income
-7.06M
Revenue
108.53K
Book val./share
6.15
Cash/share
4.25
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
12 May 2021
P/E
-4.08
Forward P/E
-0.79
PEG
0.49
P/S
265.41
P/B
0.5
P/C
0.72
P/FCF
-3.98
Quick Ratio
0.72
Current Ratio
1.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.81
EPS next Y
-3.87
EPS next Q
-0.42
EPS this Y
-68.39%
EPS next Y
377.53%
EPS next 5Y
377.53%
EPS last 5Y
-49.52%
Revenue last 5Y
-14.09%
Revenue Q/Q
-
EPS Q/Q
-99.91%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-11%
ROE
-36%
ROC
-2.1%
Gross Margin
60%
Oper. Margin
-9909%
Profit Margin
-6501%
Payout
-
Shs Outstand
10.02M
Shs Float
7.77M
-
-
-
-
Target Price
-
52W Range
1.980001-32.31003
52W High
-90.47%
52W Low
+205%
RSI
40
Rel Volume
17.55
Avg Volume
1.51M
Volume
26.47M
Perf Week
522.45%
Perf Month
412.52%
Perf Quarter
-
Perf Half Y
167.54%
-
-
-
-
Beta
-1.24035
-
-
Volatility
0.9%, 0.45%
Prev Close
507.09%
Price
3.05
Change
547.56%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2020-12-31

Metric History 2016-12-312017-12-312018-12-312019-12-31 2020-12-31
Revenue per share
8.045.934.780.70.2
Net income per share
-48.48-20.8-19.64-5.03-1.59
Operating cash flow per share
-45.88-18.32-15.46-4.86-1.34
Free cash flow per share
-46.71-18.94-16.13-4.9-1.36
Cash per share
178.7726.5612.472.990.5
Book value per share
152.31216.893.370.6
Tangible book value per share
152.31216.893.370.6
Share holders equity per share
152.31216.893.370.6
Interest debt per share
23.45.945.2201.33
Market cap
42.43M73.39M32.36M8.41M34.97M
Enterprise value
-20.66M62.2M21.11M-5.64M41.42M
P/E ratio
-2.07-2.11-0.87-0.36-2.84
Price to sales ratio
12.517.43.562.5622.02
POCF ratio
-2.19-2.4-1.1-0.37-3.36
PFCF ratio
-2.15-2.32-1.05-0.36-3.31
P/B Ratio
0.662.092.470.537.5
PTB ratio
0.662.092.470.537.5
EV to sales
-6.096.272.32-1.7226.09
Enterprise value over EBITDA
1.02-1.81-0.570.25-3.6
EV to operating cash flow
1.07-2.03-0.720.25-3.98
EV to free cash flow
1.05-1.96-0.690.24-3.92
Earnings yield
-0.48-0.47-1.16-2.81-0.35
Free cash flow yield
-0.46-0.43-0.95-2.74-0.3
Debt to equity
0.150.23000.09
Debt to assets
0.180.340.570.220.56
Net debt to EBITDA
3.110.320.310.62-0.56
Current ratio
175.171.664.591.55
Interest coverage
00000
Income quality
0.950.880.790.970.84
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.012.913.295.085.53
Research and developement to revenue
2.911.071.182.11.54
Intangibles to total assets
00000
Capex to operating cash flow
0.020.030.040.010.02
Capex to revenue
-0.1-0.11-0.14-0.06-0.11
Capex to depreciation
-1.83-3.16-2.21-0.22-0.2
Stock based compensation to revenue
0.170.330.520.910.69
Graham number
407.699.1455.1519.524.63
ROIC
-0.26-0.8-2.81-1.42-1.91
Return on tangible assets
-0.26-0.65-1.23-1.16-1.16
Graham Net
146.3918.164.152.270.04
Working capital
73.47M41.74M11.42M14.26M2.79M
Tangible asset value
00000
Net current asset value
63.59M33.77M11.37M13.69M1.88M
Invested capital
0.150.280.7602.22
Average receivables
402.5K2.3M583.5K285K1.72M
Average payables
621.5K962K903.5K648K631.5K
Average inventory
1.38M1.68M1.76M1.94M0
Days sales outstanding
55.94158.6135.3731.71724.02
Days payables outstanding
77.3196.4578.0180.18223.58
Days of inventory on hand
107.46107.18106.34239.540
Receivables turnover
6.532.310.3211.510.5
Payables turnover
4.723.784.684.551.63
Inventory turnover
3.43.413.431.520
ROE
-0.32-0.99-2.85-1.49-2.64
Capex per share
-0.83-0.62-0.67-0.04-0.02

Quarterly Fundamentals Overview

Last date of statement is 2021-06-30 for Q2

Metric History 2020-06-302020-09-302020-12-312021-03-31 2021-06-30
Revenue per share
0.090.010.0100
Net income per share
-0.54-0.2-0.17-0.440
Operating cash flow per share
-0.36-0.17-0.2-0.470.03
Free cash flow per share
-0.33-0.17-0.21-0.470.01
Cash per share
0.880.710.50.954.25
Book value per share
0.930.770.61.076.15
Tangible book value per share
0.930.770.61.07-4.96
Share holders equity per share
0.930.770.61.076.15
Interest debt per share
0.060.060.70.030.14
Market cap
5.46M7.04M11.66M26.63M47.22M
Enterprise value
-917.59K1.95M13.18M17.97M8.39M
P/E ratio
-0.33-1.13-2.2-1.6-3.03K
Price to sales ratio
7.76159.91191.08013.38K
POCF ratio
-1.98-5.45-7.5-6161.16
PFCF ratio
-2.15-5.45-7.24-6486.82
P/B Ratio
0.761.192.52.640.81
PTB ratio
0.761.192.52.640.81
EV to sales
-1.3144.37216.0802.38K
Enterprise value over EBITDA
0.23-1.45-11.77-4.49-64.49
EV to operating cash flow
0.33-1.51-8.48-4.0528.62
EV to free cash flow
0.36-1.51-8.19-4.0586.46
Earnings yield
-0.77-0.22-0.11-0.160
Free cash flow yield
-0.47-0.18-0.14-0.170
Debt to equity
0.060.070.09-0.010
Debt to assets
0.480.50.560.420.94
Net debt to EBITDA
1.63.77-1.362.16298.63
Current ratio
1.921.791.551.861.08
Interest coverage
000021.52K
Income quality
0.660.831.171.07-75.09
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.36020.1601.22
Research and developement to revenue
1.096.162.5700.03
Intangibles to total assets
00000.77
Capex to operating cash flow
000.030-0.67
Capex to revenue
00-0.890-55.54
Capex to depreciation
00-0.2601.56
Stock based compensation to revenue
0.425.891.110-100.31
Graham number
3.371.871.523.260.24
ROIC
-0.34-0.23-0.24-0.4-0.72
Return on tangible assets
-0.3-0.13-0.12-0.240
Graham Net
0.320.240.040.43-1.87
Working capital
5.18M3.98M2.79M5.93M5.11M
Tangible asset value
0000-46.82M
Net current asset value
4.08M2.99M1.88M5.55M3.72M
Invested capital
0.060.071.160.030.02
Average receivables
3.15M3.15M3.15M3.15M3.29M
Average payables
818K619K598.5K582K1.84M
Average inventory
00000
Days sales outstanding
403.276.44K4.65K087.27K
Days payables outstanding
224.261.44K55.35K0202.43K
Days of inventory on hand
0000189.29K
Receivables turnover
0.220.010.0200
Payables turnover
0.40.06000
Inventory turnover
00000
ROE
-0.58-0.26-0.28-0.410
Capex per share
00-0.010-0.02

Frequently Asked Questions

What is Obalon Therapeutics, Inc. stock symbol ?

Obalon Therapeutics, Inc. is a US stock , located in Carlsbad of California and trading under the symbol OBLN

What is Obalon Therapeutics, Inc. stock quote today ?

Obalon Therapeutics, Inc. stock price is $3.05 today.

Is Obalon Therapeutics, Inc. stock public?

Yes, Obalon Therapeutics, Inc. is a publicly traded company.

Something similar

Same Sector
Check Those
Similar Market Cap